Fish oil - An example of an anti-inflammatory food

Asia Pacific Journal of Clinical Nutrition

Volumn 14, Issue SUPPL., 2005, Pages 66-71

  Cleland, Leslie G ^a   James, Michael J ^a   Keen, Helen ^a   Danda, Debashish ^a   Caughey, Gillian ^a   Proudman, Susanna M ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Anti inflammatory; Fish oil; Inflammatory diseases; Rheumatoid arthritis

Indexed keywords

EID: 33144477610     PISSN: 09647058     EISSN: 09647058     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000; 71 (suppl): 343S-8S.
2. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ. The effect on human tumor necrosis factor a and interleukin-1b production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996; 63: 116-22.
3. Grimble RF, Howell WM, O'Reilly G, Turner SJ, Markovic O, Hirrell S, East JM, and Calder PC. 2002. The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production. Am J Clin Nutr 2002; 76: 454-9.
4. Curtis CL, Hughes CE, Flannery CR, Little CB, Harwood JL, Caterson B. n-3 Fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem 2000; 275: 721-4.
5. Kromann N, Green A. Epidemiological studies in the Upernavik district, Greenland. Acta Med. Scand 1980; 208: 401-6.
6. Welinder L, Graugaard B, Madsen M. HLA antigen and gene frequencies in Eskimos of East Greenland. Eur J Immunogenet 2000; 27: 93-7.
7. Harvald B. Genetic epidemiology of Greenland. Clin Genet 1989; 36: 364-7.
8. Kohsokabe S, Murakami H, Yamaguchi K, Tsuboi N, Murata M, Komori T, Inoue K, Hayashi T, Ito H. Prevalence of positive rheumatoid factor and results of a follow-up study in a population of 20,000. Ryumachi 1986; 26: 147-52.
9. Shichikawa K, Takenaka Y, Maeda A, Yoshino R, Tsujimoto M, Ota H, Kashiwade T, Hongo I. A longitudinal population survey of rheumatoid arthritis in a rural district in Wakayama. The Ryumachi 1981; 21 (Suppl): 35-43.
10. Shapiro JA, Koepsell TD, Voigt LF, Dugowson CE, Kestin M, Nelson JL. Diet and rheumatoid arthritis in women: A possible protective effect of fish consumption. Epidemiol 1996; 7: 256-63.
11. Prickett JD, Robinson DR, Steinberg AD. Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice. J Clin Invest 1981; 68: 556-9.
12. Robinson DR, Prickett JD, Makoul GT, Steinberg AD, Colvin RB. Dietary fish oil reduces progression of established renal disease in (NZB x NZW)F1 mice and delays renal disease in BXSB and MRL/1 strains. Arthritis Rheum 1986; 29: 539-46.
13. Prickett JD, Trentham DE, Robinson DR. Dietary fish oil augments the induction of arthritis in rats immunized with type II collagen. J Immunol 1984; 132: 725-9.
14. Robinson DR. Alleviation of autoimmune disease by dietary lipids containing omega-3 fatty acids. Rheum Dis Clin North Am 1991; 17: 213-22.
15. Cleland LG, James MJ, Proudman SM. The role of fish oils in the treatment of rheumatoid arthritis. Drugs 2003; 63: 845-53.
16. James MJ, Cleland LG. Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin Arthritis Rheum 1997; 27: 85-97.
17. Cleland LG, Proudman SM, Hall C, Stamp LK, McWilliams L, Wylie N, Neumann M, Gibson RA, James MJ. A biomarker of n-3 compliance in patients taking fish oil for rheumatoid arthritis. Lipids 2003; 38: 419-24.
18. Mason RS, Lissner D, Grunstein HS, Posen S. A simplified assay for dihydroxylated vitamin D metabolites in human serum: application to hyper- and hypovitaminosis D. Clin Chem 1980; 26: 444-50.
19. Promislow JH, Goodman-Gruen D, Slymen DJ, Barrett-Connor E. Retinol intake and bone mineral density in the elderly: the Rancho Bernardo Study. J Bone Miner Res 2002; 17: 1349-58.
20. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996; 334: 1557-60.
21. Donadio JV, Jr., Bergstralh EJ, Offord KP, Spencer DC, Holley KE. A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N Engl J Med 1994; 331:1194-9.
22. Mayser P, Grimm H, Grimminger F. n-3 fatty acids in psoriasis. Br J Nutr 2002; 87: S77-82.
23. Walton AJ, Snaith ML, Locniskar M, Cumberland AG, Morrow WJ, Isenberg DA. Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus. Ann Rheum Dis 1991;50: 463-6.
24. Ioannou Y, Isenberg DA. Current concepts for the management of systemic lupus erythematosus in adults: a therapeutic challenge. Postgrad Med J 2002; 78: 599-606.
25. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM. Effect of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989; 334: 757-61.
26. GISSI Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447-55.
27. Leaf A, Kang JX, Xiao YF, Billman GE. n-3 fatty acids in the prevention of cardiac arrhythmias. Lipids 1999; 34 Suppl: S187-9.
28. Dyerberg J, Bang HO. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 1979; 2: 433-5.
29. Eritsland J, Arnesen H, Seljeflot I, Kierulf P. Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease. Blood Coagul Fibrinolysis 1995; 6: 17-22.
30. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ, Weaver A. Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis. N Engl J Med 2000; 343: 1520-8.
31. Calder PC. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond) 2004; 107: 1-11.
32. Darlametsos IE, Varonos DD. Role of prostanoids and endothelins in the prevention of cyclosporine-induced nephrotoxicity. Prostaglandins Leukot Essent Fatty Acids 2001; 64: 231-9.
33. Zurier RB, Rossetti RG, Jacobson EW, DeMarco DM, Liu NY, Temming JE, White BM, Laposata M. gamma-Linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial. Arthritis Rheum 1996; 39: 1808-17.